company background image
A048530

iNtRON Biotechnology KOSDAQ:A048530 Stock Report

Last Price

₩8.65k

Market Cap

₩289.2b

7D

1.8%

1Y

-50.9%

Updated

27 Jan, 2023

Data

Company Financials +

iNtRON Biotechnology, Inc.

KOSDAQ:A048530 Stock Report

Mkt Cap: ₩289.2b

A048530 Stock Overview

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide.

A048530 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance4/6
Financial Health4/6
Dividends0/6

Rewards

Revenue is forecast to grow 12.14% per year

Earnings grew by 6.3% over the past year

Risk Analysis

No risks detected for A048530 from our risk checks.

My Notes

New

Notes are coming soon

iNtRON Biotechnology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for iNtRON Biotechnology
Historical stock prices
Current Share Price₩8,650.00
52 Week High₩23,300.00
52 Week Low₩7,790.00
Beta0.68
1 Month Change3.22%
3 Month Change-0.23%
1 Year Change-50.85%
3 Year Change-26.38%
5 Year Change-60.82%
Change since IPO116.25%

Recent News & Updates

Recent updates

We Think iNtRON Biotechnology (KOSDAQ:048530) Can Stay On Top Of Its Debt

May 03
We Think iNtRON Biotechnology (KOSDAQ:048530) Can Stay On Top Of Its Debt

We Believe iNtRON Biotechnology's (KOSDAQ:048530) Earnings Are A Poor Guide For Its Profitability

Mar 24
We Believe iNtRON Biotechnology's (KOSDAQ:048530) Earnings Are A Poor Guide For Its Profitability

Does iNtRON Biotechnology's (KOSDAQ:048530) Share Price Gain of 81% Match Its Business Performance?

Feb 28
Does iNtRON Biotechnology's (KOSDAQ:048530) Share Price Gain of 81% Match Its Business Performance?

iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) Stock Is Going Strong: Is the Market Following Fundamentals?

Jan 31
iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) Stock Is Going Strong: Is the Market Following Fundamentals?

iNtRON Biotechnology (KOSDAQ:048530) Has A Rock Solid Balance Sheet

Jan 05
iNtRON Biotechnology (KOSDAQ:048530) Has A Rock Solid Balance Sheet

What iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) 26% Share Price Gain Is Not Telling You

Dec 10
What iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) 26% Share Price Gain Is Not Telling You

iNtRON Biotechnology (KOSDAQ:048530) Share Prices Have Dropped 49% In The Last Five Years

Nov 26
iNtRON Biotechnology (KOSDAQ:048530) Share Prices Have Dropped 49% In The Last Five Years

Shareholder Returns

A048530KR BiotechsKR Market
7D1.8%0.6%3.8%
1Y-50.9%-20.2%-6.9%

Return vs Industry: A048530 underperformed the KR Biotechs industry which returned -20.2% over the past year.

Return vs Market: A048530 underperformed the KR Market which returned -6.9% over the past year.

Price Volatility

Is A048530's price volatile compared to industry and market?
A048530 volatility
A048530 Average Weekly Movement6.1%
Biotechs Industry Average Movement6.6%
Market Average Movement5.4%
10% most volatile stocks in KR Market10.6%
10% least volatile stocks in KR Market3.1%

Stable Share Price: A048530 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: A048530's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199987Alek Yoonhttps://www.intron.co.kr

iNtRON Biotechnology, Inc. develops biopharmaceuticals for the prevention and treatment of human diseases worldwide. It develops bacteriophage and endoricin drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.

iNtRON Biotechnology, Inc. Fundamentals Summary

How do iNtRON Biotechnology's earnings and revenue compare to its market cap?
A048530 fundamental statistics
Market Cap₩289.24b
Earnings (TTM)₩11.83b
Revenue (TTM)₩19.68b

24.5x

P/E Ratio

14.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A048530 income statement (TTM)
Revenue₩19.68b
Cost of Revenue₩5.22b
Gross Profit₩14.46b
Other Expenses₩2.63b
Earnings₩11.83b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)352.98
Gross Margin73.46%
Net Profit Margin60.11%
Debt/Equity Ratio16.5%

How did A048530 perform over the long term?

See historical performance and comparison